Publications by authors named "Aldo Torre"

Claim this Profile
E
Enhancement of Inpatient Mortality Prognostication With Machine Learning in a Prospective Global Cohort of Patients With Cirrhosis With External Validation.
Scott Silvey, Patrick S Kamath, Jacob George, Ashok Choudhury, Qing Xie, Aldo Torre

Gastroenterology· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for autoimmune liver disease recurrence after liver transplantation.
Moisés Salgado-de la Mora, Osvely Mendez-Guerrero, Aldo Torre, Mario Vilatoba, Graciela E Castro Narro

World J Transplant· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining Organ Failures in Patients With Cirrhosis: Consensus Statements.
Jasmohan S Bajaj, Debbie L Shawcross, Ashok Choudhury, Constantine J Karvellas, Jacqueline G O'Leary, Aldo Torre

Gastroenterology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV patients with residual fibrosis after DAA treatment re-establish their epigenetic signature after prolonged-release pirfenidone: MINERVA study.
Eira Cerda-Reyes, Ricardo de la Rosa-Bibiano, Ana Sandoval-Rodriguez, Rebeca Rosas-Campos, Aldo Torre

Clin Epigenetics· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Use of Terlipressin in Cirrhosis and Acute Kidney Injury: Frequent Use Beyond Hepatorenal Syndrome.
Ann T Ma, Adrià Juanola, Kavish R Patidar, Anna Barone, Simone Incicco, Aldo Torre

Clin Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay between endocrine disorders and liver dysfunction: Mechanisms of damage and therapeutic approaches.
Andres M Vargas-Beltran, Samantha M Armendariz-Pineda, Froylan D Martínez-Sánchez, Carolina Martinez-Perez, Aldo Torre

World J Gastroenterol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis.
Jonel Trebicka, Ferran Aguilar, Alberto Queiroz Farias, Juan-José Lozano, Cristina Sánchez-Garrido, Aldo Torre

Gut· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Failure, Hepatic Encephalopathy, and Infection Contribute to Mortality Risk in a Global Cirrhosis Cohort.
Jasmohan S Bajaj, Scott Silvey, Aidan Mullan, Ashok Choudhury, Florence Wong, Aldo Torre

Clin Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain reserve in hepatic encephalopathy: Pathways of damage and preventive strategies through lifestyle and therapeutic interventions.
Jacqueline Cordova-Gallardo, Andres Manuel Vargas-Beltran, Samantha Melanie Armendariz-Pineda, Jesus Ruiz-Manriquez, Javier Ampuero, Aldo Torre

Ann Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive Evaluation of Prolonged-Release Pirfenidone in Compensated Liver Cirrhosis. ODISEA Study, a Randomised Trial.
Linda E Muñoz-Espinosa, Aldo Torre, Laura Cisneros, Iaarah Montalvo, René Malé, Lilian Torres

Liver Int· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study.
Kavish R Patidar, Ann T Ma, Adrià Juanola, Anna Barone, Simone Incicco, Aldo Torre

Lancet Gastroenterol Hepatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic encephalopathy: risk identification and prophylaxis approaches.
Aldo Torre, Jacqueline Córdova-Gallardo, Froylan David Martínez-Sánchez

Metab Brain Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium.
Zhujun Cao, Florence Wong, Ashok K Choudhury, Patrick S Kamath, Mark Topazian, Aldo Torre

Lancet Gastroenterol Hepatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pirfenidone use in fibrotic diseases: What do we know so far?
Aldo Torre, Froylan David Martínez-Sánchez, Sofía Mercedes Narvaez-Chávez, Mariana Ariel Herrera-Islas, Carlos Alberto Aguilar-Salinas

Immun Inflamm Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus document on acute-on-chronic liver failure (ACLF) established by the Mexican Association of Hepatology.
Aldo Torre, Laura Esthela Cisneros-Garza, Mauricio Castillo-Barradas, Nalu Navarro-Alvarez, Ricardo Sandoval-Salas

Ann Hepatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm!
Jasmohan S Bajaj, Ashok Choudhury, Vinay Kumaran, Florence Wong, Wai Kay Seto, Aldo Torre

Am J Transplant· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing nutrition in hepatic cirrhosis: A comprehensive assessment and care approach.
Osvely Mendez-Guerrero, Anaisa Carranza-Carrasco, Luis Alberto Chi-Cervera, Aldo Torre, Nalu Navarro-Alvarez

World J Gastroenterol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rifaximin Alfa and Liver Diseases: More Than a Treatment for Encephalopathy, a Disease Modifier.
Aldo Torre, Jacqueline Córdova-Gallardo, Alberto C Frati Munari

Ther Clin Risk Manag· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America.
Alberto Queiroz Farias, Anna Curto Vilalta, Patricia Momoyo Zitelli, Gustavo Pereira, Luciana L Goncalves, Aldo Torre

Gastroenterology· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium.
Jasmohan S Bajaj, Ashok K Choudhury, Qing Xie, Patrick S Kamath, Mark Topazian, Aldo Torre

Lancet Gastroenterol Hepatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silymarin in the management of liver enzyme activity in steatohepatitis: a case report.
Aldo Torre

Drugs Context· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a re-linkage to care strategy in patients with chronic hepatitis C who were lost to follow-up in Latin America.
Manuel Mendizabal, Marcos Thompson, Esteban Gonzalez-Ballerga, Margarita Anders, Graciela E Castro-Narro, Aldo Torre

J Viral Hepat· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stool microbiota show greater linkages with plasma metabolites compared to salivary microbiota in a multinational cirrhosis cohort.
Isobel Jane Cox, Marcela Peña Rodríguez, Andrew Fagan, Mayra V Rojas-Lara, Adrien Le Guennec, Aldo Torre

Liver Int· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galectin-3 is overexpressed in advanced cirrhosis and predicts post-liver transplant infectious complications.
Eduardo Cervantes-Alvarez, Nathaly Limon-de la Rosa, Mario Vilatoba, Carlos Pérez-Monter, Sahara Hurtado-Gomez, Elisa Alatorre-Arenas, Aldo Torre

Liver Int· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver transplantation is beneficial regardless of cirrhosis stage or acute-on-chronic liver failure grade: A single-center experience.
Eduardo Cervantes-Alvarez, Mario Vilatoba, Nathaly Limon-de la Rosa, Osvely Mendez-Guerrero, David Kershenobich, Aldo Torre

World J Gastroenterol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis